Back to search

Netherlands· NL-a9c19a2c49d6

Triamcinolonacetonide Addimed suspensie voor injectie 40 mg/ml

A triamcinolone product containing triamcinolonacetonide, registered in Netherlands by Addimed Pharma B.V.. The same ATC class is registered in 14 of our 19 countries.

ATC H02AB08

Checked against CBG-MEB (Netherlands) on

Informational only — not a medical device.

SOURCE REGISTER · NLCBG-MEB (Netherlands)normalisedTriamcinolonacetonide Addimed suspens…ATCH02AB08REGISTER NO.NL-a9c19a2c49d6PACKS LISTED1CHECKEDSeptember 29, 2026

Where it is registered

Triamcinolone is registered in 14 of 19 countries.

Countries holding a registration under ATC H02AB08 (triamcinolone), each read from that country’s own register.

  • This record: Netherlands, from CBG-MEB (Netherlands)
  • 8 of them publish a price we can compare per daily dose

Triamcinolone · ATC H02AB08

14 / 19 countries

  • Belgiumprice
  • Canada
  • Czechiaprice
  • Denmark
  • Finlandprice
  • Germany
  • Icelandprice
  • Italyprice
  • Japan
  • Netherlands
  • Norwayprice
  • Polandprice
  • Switzerlandprice
  • United Kingdom
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

Price per daily dose

What a daily dose of triamcinolone costs, country by country.

Normalised to the WHO defined daily dose (7.5 mg), so markets compare like for like.

  • 1 market with a comparable price for this class
  • Public list prices, converted to USD at the rate date shown

Triamcinolone · price per daily dose (7.5 mg)

USD · FX 28 Sept 2026

  • CH Switzerland$1.42
Median listed price per WHO defined daily dose, in each market that publishes a price. Open the full comparison

The record

At a glance

CBG-MEB (Netherlands)
Active substance
TRIAMCINOLONACETONIDE
Manufacturer
Addimed Pharma B.V.
Country
Netherlands (NL)
ATC code
H02AB08
ATC class
Triamcinolone
Defined daily dose
7.5 mg, O
Reimbursed
Not published by this register
Source register
CBG-MEB (Netherlands)
Last checked
September 29, 2026

Packs & prices · 1

  • cbg_meb_id
    130697//05341

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Interactions

806 interactions on record for triamcinolone.

Graded by severity as the source publishes them — 84 severe. Severity grades are free for everyone; mechanism and management come with Growth.

  • Severity for every pair — free, no plan needed
  • The source, licence and sync date on every record
  • Mechanism and what to do for each pair — Growth plan

Triamcinolone · interactions on record

806 records

  • 84 severe
  • 366 moderate
  • 38 minor
  • 298 info

Most severe, free to view

  • LonafarnibA16AX20severe
  • DesirudinB01AE01severe
  • ConivaptanC03XA02severe
  • Magnesium hydroxideA02AA04moderate

20 more interactions with mechanism and management, from a commercially licensed source.

Sign in to check
  • Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Mechanism and what to do, in the interaction check
Source: DDInter 2.0 · synced 29 Sept 2026. Grades as the source publishes them.

Same medicine, other countries

Triamcinolone in 16 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All triamcinolone products

Authorised across Europe · EMA

The same active substance is authorised in 27 EEA countries. Names it is sold under:

  • Austria · Volon, Volon A
  • Belgium · Delphi, Kenacort-A
  • Cyprus · Triacort
  • Czechia · Triamcinolon Léčiva
  • Germany · Nasacort, Rhinisan
  • Denmark · Kenalog, Triamcinolone Acetonide Medipha
  • Estonia · Kenalog
  • Spain · Nasacort
  • Finland · Nasacort, Triamcinolone Medipha
  • France · Kenacort Retard, Nasacort
  • United Kingdom (Northern Ireland) · Nasacort
  • Greece · Jiven, Nasacort
  • Croatia · Kenalog
  • Hungary · Ftorocort, Kenalog
  • Ireland · Nasacort, Nasacort Allergy
  • Iceland · Kenacort-T, Nasacort
  • Italy · Kenacort, Nasacort
  • Lithuania · Ftorocort, Kenalog
  • Luxembourg · Delphi, Kenacort-A
  • Latvia · Ftorocort, Kenalog
  • Malta · Nasacort, Nasacort Allergy
  • Norway · Kenacort-T, Nasacort
  • Poland · Polcortolon
  • Portugal · Nasacort, Telfast Spray Nasal
  • Sweden · Kenacort-T, Nasacort
  • Slovenia · Kenalog
  • Slovakia · Triamcinolon Crm Léčiva, Triamcinolon Ung Léčiva

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of CBG-MEB (Netherlands). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/fef12c4e-8c0f-42a3-9162-6846e4efbce8
GET /v1/drugs/fef12c4e-8c0f-42a3-9162-6846e4efbce8?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "form": "Suspensie voor injectie",
  "route": null,
  "soort": "RVG",
  "source": "cbg_meb",
  "smpc_url": "https://www.geneesmiddeleninformatiebank.nl/smpc/h05341_smpc.pdf",
  "strength": null,
  "atc_label": "Triamcinolone",
  "detail_url": "https://www.geneesmiddeleninformatiebank.nl/nl/rvg130697",
  "excipients": [
    "BENZYLALCOHOL (E 1519)",
    "CARMELLOSE NATRIUM (E 466)",
    "NATRIUMCHLORIDE",
    "POLYSORBAAT 80 (E 433)",
    "WATER VOOR INJECTIE"
  ],
  "substances": [
    "TRIAMCINOLONACETONIDE"
  ],
  "leaflet_url": "https://www.geneesmiddeleninformatiebank.nl/bijsluiters/h130697.pdf",
  "authorised_at": "2023/09/11",
  "procedure_number": null,
  "dispensing_status": "Uitsluitend recept",
  "registration_number": "130697//05341",
  "additional_monitoring": "N"
}

See everything about triamcinolone.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.